Goodwin Procter has advised Stago, while Dechert has advised ARCHIMED. The Stago Group, a global leader in diagnostics and hemostasis, has entered into exclusive negotiations with...
Stago Enters Exclusive Negotiations for Majority Stake Acquisition by ARCHIMED and La Caisse
Roche and Foundation Medicine’s Partnership with Gustave Roussy
Dechert advised Roche and Foundation Medicine in their partnership. Roche and Foundation Medicine announced their partnership with Gustave Roussy, the leading cancer center in Europe, to...
Novartis and Roche’s Appeal Against the French Competition Authority
Fréget Glaser & Associés assisted the Novartis laboratory in its appeal against the Competition Authority’s decision. The Roche laboratory was advised by Dechert LLP. Novartis has...
Havea’s Acquisition of Biocyte
Dechert advised Havea. PwC Société d’Avocats carried out tax due diligence on behalf of Havea Group. Havea Group has announced that it has entered into exclusive negotiations...
Chiesi Farmaceutici’s Acquisition of Amryt Pharma Plc
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
ArchiMed’s Acquisition of Carso
The Paul Hastings team advised the shareholders of Carso, while Dechert advised ArchiMed on the deal. ArchiMed, a leading investment firm exclusively dedicated to the healthcare...
Voyageurs du Monde’s €130 Million Financing Round
IN BRIEF: Allen & Overy, Dechert, advised on the matter. Allen & Overy advised Crédit Mutuel Equity with a team including Fr??ic Moreau (Corporate M&A), Romy...